1. Home
  2. LABT vs GCDT Comparison

LABT vs GCDT Comparison

Compare LABT & GCDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lakewood-Amedex Biotherapeutics Inc. Common Stock

LABT

Lakewood-Amedex Biotherapeutics Inc. Common Stock

N/A

Current Price

$2.20

Market Cap

5.3M

Sector

Health Care

ML Signal

N/A

GCDT

Green Circle Decarbonize Technology Limited Ordinary Shares

N/A

Current Price

$0.44

Market Cap

5.3M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
LABT
GCDT
Founded
N/A
1992
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
5.3M
5.3M
IPO Year
2026
2022

Fundamental Metrics

Financial Performance
Metric
LABT
GCDT
Price
$2.20
$0.44
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
350.5K
20.1M
Earning Date
N/A
05-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.66
$0.33
52 Week High
$6.85
$5.32

Technical Indicators

Market Signals
Indicator
LABT
GCDT
Relative Strength Index (RSI) 47.73 48.17
Support Level $1.89 $0.33
Resistance Level $2.48 $0.57
Average True Range (ATR) 0.34 0.11
MACD -0.00 0.01
Stochastic Oscillator 27.02 9.62

Price Performance

Historical Comparison
LABT
GCDT

About LABT Lakewood-Amedex Biotherapeutics Inc. Common Stock

Lakewood-Amedex Biotherapeutics Inc is a clinical-stage biotechnology company developing a novel class of fast-acting, broad-spectrum antimicrobials - the Bisphosphocin class - to treat infectious diseases and reduce the threat posed by antibiotic-resistant bacterial strains, including MRSA, VRE, and others. The company's main product is Nu-3, a topically delivered antimicrobial gel in Phase 2 clinical trials for the treatment of mildly infected diabetic foot ulcers (iDFU). It is also advancing a portfolio of early-stage pipeline compounds developed from its Bisphosphocin platform targeting potential disease indications, including complicated urinary tract infection (cUTI) and pulmonary infections.

About GCDT Green Circle Decarbonize Technology Limited Ordinary Shares

Green Circle Decarbonize Technology Ltd is a company which provides advanced energy saving solutions supported by proprietary phase change thermal energy storage materials and thermal engineering services. As an advocate of decarbonization, the Company designs, develops and provides customized energy saving solutions that bring considerable economic benefits to our clients and reduce carbon emissions for a sustainable future.

Share on Social Networks: